Alleviation of Abdominal Pain due to Irinotecan-Induced Cholinergic Syndrome Using Loperamide: A Case Report
Irinotecan hydrochloride (irinotecan) is a chemotherapeutic agent used in the treatment of solid tumors. In addition to severe neutropenia and delayed diarrhea, irinotecan causes cholinergic syndrome, characterized by abdominal pain and acute diarrhea. The latter symptoms are frequently observed dur...
Main Authors: | Kazuki Uchiyama, Yoshitaka Saito, Yoh Takekuma, Satoshi Yuki, Mitsuru Sugawara |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-06-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/516403 |
Similar Items
-
Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons
by: Rachel M. McQuade, et al.
Published: (2017-06-01) -
A Heart-Wrenching Case of Loperamide Toxicity
by: Sadaf Sheikh, et al.
Published: (2019-12-01) -
Enhancement of Loperamide
Dissolution Rate by Liquisolid Compact Technique
by: Kambham Venkateswarlu, et al.
Published: (2016-09-01) -
Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
by: Blasco Alejandro, et al.
Published: (2020-05-01) -
Changes in the Gut Microbiome after Galacto-Oligosaccharide Administration in Loperamide-Induced Constipation
by: Min Guk Kim, et al.
Published: (2020-10-01)